Zevra Therapeutics
Price & Volume
Stats
See more52W Range | $4.20-$9.76 |
Market Cap | $503.3M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $24.4M |
Revenue Growth (YoY) | 27.6% |
Gross Profit (12 Mos) | $10.1M |
Diluted EPS | -$2.13 |
News
See moreYahoo Finance • 2 months ago
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
Yahoo Finance • last year
Zevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial Results
Yahoo Finance • 2 years ago
Zevra Therapeutics Reports Corporate Updates and First Quarter 2023 Financial Results
Yahoo Finance • 2 years ago
Zevra Therapeutics Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Corporate Updates
About
CEO | Mr. Neil F. McFarlane |
CFO | Mr. R. LaDuane Clifton CPA |
Address | 1180 Celebration Boulevard, Celebration, FL, United States, 34747 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 65 |
